Amgen Inc.
A biotechnology company that makes medicines for serious illnesses, including the bone-strengthening drug Prolia, the cholesterol-lowering injection Repatha, and the psoriasis treatment Otezla, sold to patients and doctors worldwide. It was founded in 1980 in Thousand Oaks, California, as Applied Molecular Genetics, a name later shortened to "Amgen." Its first CEO famously ran the company from a small trailer so scientists could use the office space, and early experiments included trying to extract oil from shale and accelerate chicken growth.
Granted 356.9K
Granted 126.6K · Sold 63.5K
Granted 72.0K · Sold 25.2K
Granted 55.9K
Granted 75.8K · Sold 33.9K
Granted 4.5K
Granted 83.8K · Sold 48.5K
Granted 32.1K
Granted 24.0K · Sold 6.6K
Granted 1.8K
Granted 4.0K
Granted 4.6K
Granted 6.0K
Granted 4.0K
Granted 13.9K · Sold 2.0K
Granted 2.0K
Granted 11.1K · Sold 2.8K
Granted 4.0K
Granted 4.0K
Granted 14.4K · Sold 12.0K
Granted 6.0K
Granted 1.8K · Sold 800
Granted 5.4K
Granted 4.0K
Granted 3.2K · Sold 2.0K
Granted 2.2K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Bradway Robert AChairman, CEO and President, Director · 36 transactions | — | 655.2K | 356.9K | — | — |
| Santos EstebanEVP, Operations · 37 transactions | +61.4% | 83.8K | 126.6K | — | 63.5K |
| Gordon MurdoEVP, Global Commercial Ops · 35 transactions | +14.2% | 51.2K | 72.0K | — | 25.2K |
| Griffith Peter H.EVP & CFO · 29 transactions | +93.2% | 50.1K | 55.9K | — | — |
| Reese David MEVP & Chief Technology Officer · 39 transactions | -5% | 42.3K | 75.8K | — | 33.9K |
| Johnston Lori AEVP, HR · 2 transactions | +9.4% | 40.9Kas of Mar 2022 | 4.5K | — | — |
| Graham Jonathan PEVP & Gen. Counsel & Sec. · 40 transactions | -14.8% | 39.7K | 83.8K | — | 48.5K |
| Bradner James E.EVP, Research and Development · 9 transactions | — | 30.0K | 32.1K | — | — |
| Eckert RobertDirector · 8 transactions | +98.9% | 26.3K | 24.0K | — | 6.6K |
| Sugar Ronald DDirector · 2 transactions | +17.4% | 19.7Kas of May 2023 | 1.8K | — | — |
| Jacks TylerDirector · 5 transactions | +47.3% | 18.3K | 4.0K | — | — |
| Kullman Ellen JamisonDirector · 9 transactions | +75.9% | 14.5K | 4.6K | — | — |
| Holley Charles MDirector · 16 transactions | +108.8% | 14.1K | 6.0K | — | — |
| Garland Greg C.Director · 5 transactions | +40.4% | 13.8K | 4.0K | — | — |
| Miller DerekSVP, Human Resources · 35 transactions | — | 12.4K | 13.9K | — | 2.0K |
| Louie Linda H.VP, Finance & CAO · 15 transactions | +20.6% | 10.0Kas of May 2023 | 2.0K | — | — |
| Khosla RachnaSVP, Business Development · 42 transactions | — | 8.4K | 11.1K | — | 2.8K |
| Druker BrianDirector · 5 transactions | +130.9% | 8.4K | 4.0K | — | — |
| Austin Wanda MDirector · 5 transactions | +98.9% | 8.0K | 4.0K | — | — |
| Grygiel Nancy A.SVP & CCO · 47 transactions | -40.8% | 7.4K | 14.4K | — | 12.0K |
| Ishrak OmarDirector · 18 transactions | +687% | 7.4K | 6.0K | — | — |
| Williams R SandersDirector · 4 transactions | +18.9% | 6.2Kas of May 2023 | 1.8K | — | 800 |
| Drake Michael VDirector · 16 transactions | — | 5.8K | 5.4K | — | — |
| Miles Amy EDirector · 5 transactions | +353% | 5.6K | 4.0K | — | — |
| Busch Matthew C.VP, Finance & CAO · 25 transactions | — | 4.3K | 3.2K | — | 2.0K |
| Klotman Mary E.Director · 3 transactions | — | 2.2K | 2.2K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: -197.4K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.